Chenodeoxycholic Acid /Ursodeoxycholic Acid

鹅去氧胆酸/熊去氧胆酸

Report date: 2025/08/19 09:46:58
NME

Base Information

Drug NameChenodeoxycholic Acid /Ursodeoxycholic Acid
Drug Alias NameMagnesium Salt Trihydrate of Chenodeoxycholic Acid and Ursodeoxycholic Acid
ClassificationSmall molecules > Steroids
Mechanisms of ActionImmunosuppressantsImmunomodulatorsApoptosis inhibitors +[6] 
TargetsBile acid receptor FXRCytochrome P450 7A1Cholesterol
Therapy Area/IndicationsDyspepsiaCholelithiasis
Global Approved IndicationsDyspepsiaCholelithiasis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date1992/02/24
Country/TerritorySouth Korea
CombinationsYes Ursodeoxycholic acidChenodeoxycholic acid
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMyungmoon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMyungmoon Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsDyspepsiaCholelithiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A